CORC

在结果中检索

CORC

浏览/检索结果: 共8条，第1-8条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Tumoral cavitation in colorectal cancer patients with unresectable lung metastasis treated with bevacizumab and chemotherapy. 期刊论文
Journal of cancer research and clinical oncology, 2018
作者:  Peng, Y;  Chen, Y;  Zhang, X;  Yang, Y;  Cao, D
收藏  |  浏览/下载：2/0  |  提交时间：2019/02/25
The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis 期刊论文
Frontiers in Pharmacology, 2016, 卷号: Vol.7, 页码: 70
作者:  Xiao Ma;  Rui-Sheng Li;  Jian Wang;  Yin-Qiu Huang;  Peng-Yan Li
收藏  |  浏览/下载：7/0  |  提交时间：2019/02/25
Meta-analysis: traditional Chinese medicine for improving immune response in patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. 期刊论文
Explore (New York, N.Y.), 2011, 卷号: Vol.7 No.1, 页码: 37-43
作者:  Meng MB;  Wen QL;  Cui YL;  She B;  Zhang RM
收藏  |  浏览/下载：3/0  |  提交时间：2019/03/01
Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis 期刊论文
Radiotherapy and Oncology, 2009, 卷号: Vol.92 No.2, 页码: 184-194
作者:  Mao-Bin Meng;  Yao-Li Cui;  You Lu;  Bin She;  Yan Chen
收藏  |  浏览/下载：1/0  |  提交时间：2019/02/28
Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. 期刊论文
Journal of Alternative and Complementary Medicine, 2008, 卷号: Vol.14 No.8, 页码: 1027-1042
作者:  Meng M;  Cui Y;  Guan Y;  Ying Z;  Zheng M
收藏  |  浏览/下载：2/0  |  提交时间：2019/03/26
Phase 2 Trial of Cisplatin (C), Etoposide (E), and Radiation (RT) Followed by Gemcitabine (G) Vs G and Docetaxel (D) in Stage III A/B Unresectable Non-small-cell Lung Cancer (NSCLC): P2-195. 期刊论文
Journal of Thoracic Oncology, 2007, 卷号: Vol.2 No.8
作者:  Benjamin Movsas;  Corey Langer;  L.H. Wang;  Robert Jotte;  F Xu
收藏  |  浏览/下载：2/0  |  提交时间：2019/03/26
Phase II trial of cisplatin (C), etoposide (E) and radiation (RT) followed by gemcitabine (G) vs G and docetaxel (D) in stage III A/B unresectable non-small cell lung cancer (NSCLC) 期刊论文
Journal of Clinical Oncology, 2006, 卷号: Vol.24 No.18Suppl, 页码: 7120
-
收藏  |  浏览/下载：2/0  |  提交时间：2019/03/05
Phase II trial of cisplatin (C), etoposide (E) and radiation (RT) followed by gemcitabine (G) vs G and docetaxel (D) in stage III A/B unresectable non-small cell lung cancer (NSCLC). 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2006, 卷号: Vol.24 No.18, 页码: 394S
作者:  Movsas, B.;  Langer, C.;  Wang, L. H.;  Jotte, R. M.;  Xu, F.
收藏  |  浏览/下载：1/0  |  提交时间：2019/02/25

©版权所有 ©2017 CSpace - Powered by CSpace